sEVs can facilitate tumor progression by delivering oncogenic proteins such as EGFR and ANXA2 to promote angiogenesis42,43, activate intracellular signaling pathways such as the PI3/Akt axis to enhance DNA repair and cell proliferation44, and suppress apoptosis through microRNA-mediated regulation45. Here, ANXA2 is linked to neoplasm.